The story of the erectile dysfunction drug presents a complex picture for investors. While the initial release generated massive returns, the lapse of its patent opened the door to generic competitors, dramatically https://kathrynnfbb745712.dbblog.net/15145146/viagra-and-pharma-a-volatile-opportunity